Loading...
Akzo Nobel N.V.
AKZA.AS•EURONEXT
Basic Materials
Chemicals - Specialty
€57.36
€-2.02(-3.40%)
Akzo Nobel N.V. (AKZA.AS) Financial Performance & Statements
Review Akzo Nobel N.V.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.40%
↑ 0.40%
Operating Income Growth
-10.88%
↓ 10.88%
Net Income Growth
22.62%
↑ 22.62%
Operating Cash Flow Growth
-39.91%
↓ 39.91%
Operating Margin
7.97%
↑ 7.97%
Gross Margin
40.23%
↑ 40.23%
Net Profit Margin
4.38%
↑ 4.38%
ROE
10.26%
↑ 10.26%
ROIC
8.47%
↑ 8.47%
Akzo Nobel N.V. (AKZA.AS) Financial Statements
Explore quarterly and annual reports for Akzo Nobel N.V. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $2.61B | $2.62B | $2.67B | $2.78B |
| Cost of Revenue | $1.56B | $1.59B | $1.58B | $1.64B |
| Gross Profit | $1.05B | $1.03B | $1.08B | $1.14B |
| Gross Profit Ratio | $0.40 | $0.39 | $0.41 | $0.41 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $855.00M | $898.00M | $819.00M | $872.00M |
| Operating Expenses | $856.00M | $899.00M | $819.00M | $872.00M |
| Total Costs & Expenses | $2.42B | $2.49B | $2.40B | $2.52B |
| Interest Income | $0.00 | $0.00 | $12.00M | $16.00M |
| Interest Expense | $30.00M | $36.00M | $44.00M | $47.00M |
| Depreciation & Amortization | $94.00M | $94.00M | $96.00M | $92.00M |
| EBITDA | $298.00M | $225.00M | $380.00M | $369.00M |
| EBITDA Ratio | $0.11 | $0.09 | $0.14 | $0.13 |
| Operating Income | $192.00M | $127.00M | $264.00M | $269.00M |
| Operating Income Ratio | $0.07 | $0.05 | $0.10 | $0.10 |
| Other Income/Expenses (Net) | -$23.00M | -$32.00M | -$17.00M | -$26.00M |
| Income Before Tax | $169.00M | $95.00M | $247.00M | $239.00M |
| Income Before Tax Ratio | $0.06 | $0.04 | $0.09 | $0.09 |
| Income Tax Expense | $48.00M | $59.00M | $77.00M | $53.00M |
| Net Income | $107.00M | $21.00M | $163.00M | $177.00M |
| Net Income Ratio | $0.04 | $0.008 | $0.06 | $0.06 |
| EPS | $0.63 | $0.12 | $0.95 | $1.04 |
| Diluted EPS | $0.62 | $0.12 | $0.95 | $1.03 |
| Weighted Avg Shares Outstanding | $170.80M | $170.80M | $170.80M | $170.70M |
| Weighted Avg Shares Outstanding (Diluted) | $172.58M | $170.80M | $170.80M | $171.84M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan